Results 111 to 120 of about 452,929 (122)

Grupos de investigación y extensión

open access: yesVitae, 2009
Facultad Química Farmacéutica
doaj  

Use of the MOF NU-1000 as a Drug Delivery System for the Antineoplastic Drug Mitoxantrone. [PDF]

open access: yesInt J Mol Sci
Alfonso DR   +7 more
europepmc   +1 more source

Evaluadores

open access: yesVitae, 2009
Facultad Química Farmacéutica
doaj  

Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer. [PDF]

open access: yesBreast
Gianni L   +23 more
europepmc   +1 more source

Type 2 Diabetes Mellitus Exacerbates Brain Injury After <i>Status Epilepticus</i> in Rats. [PDF]

open access: yesBrain Sci
Mérida-Portilla CV   +5 more
europepmc   +1 more source

Resveratrol reverses cassava (Manihot esculenta Crantz) juice-induced motor impairment in the Wistar rat. [PDF]

open access: yesBMC Complement Med Ther
Rivadeneyra-Domínguez E   +5 more
europepmc   +1 more source

Development and Characterization of Trihexyphenidyl Orodispersible Minitablets: A Challenge to Fill the Therapeutic Gap in Neuropediatrics. [PDF]

open access: yesPharmaceutics
Olivera C   +7 more
europepmc   +1 more source

Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: <i>in vivo</i> efficacy in a murine model of chemotherapy-induced neuropathic pain. [PDF]

open access: yesJ Enzyme Inhib Med Chem
Codony S   +25 more
europepmc   +1 more source

Programas de pregrado

open access: yesVitae, 2009
Facultad Química Farmacéutica
doaj  

Home - About - Disclaimer - Privacy